Ocugen Inc. [OCGN] Revenue clocked in at $-0.00 million, down -48.57% YTD: What’s Next?



Ocugen Inc. [NASDAQ: OCGN] stock went on an upward path that rose over 6.85% on Monday, amounting to a one-week price decrease of less than -5.65%. The company report on May 2, 2022 that Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and vaccines, today announced that it will host a conference call to provide a business update and discuss its first quarter 2022 financial results at 8:30 a.m. ET on Friday, May 6, 2022.

Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details:.

Over the last 12 months, OCGN stock dropped by -85.08%. The one-year Ocugen Inc. stock forecast points to a potential upside of 71.64. The average equity rating for OCGN stock is currently 2.50, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $528.16 million, with 199.25 million shares outstanding and 195.14 million shares in the current float. Compared to the average trading volume of 11.13M shares, OCGN stock reached a trading volume of 7272383 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Ocugen Inc. [OCGN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OCGN shares is $8.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OCGN stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Noble Capital Markets have made an estimate for Ocugen Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 26, 2021. While these analysts kept the previous recommendation, ROTH Capital raised their target price from $10 to $6. The new note on the price target was released on June 11, 2021, representing the official price target for Ocugen Inc. stock. On February 09, 2021, analysts increased their price target for OCGN shares from 0.70 to 13.

The Average True Range (ATR) for Ocugen Inc. is set at 0.24 The Price to Book ratio for the last quarter was 4.87, with the Price to Cash per share for the same quarter was set at 0.42.

OCGN Stock Performance Analysis:

Ocugen Inc. [OCGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.65. With this latest performance, OCGN shares dropped by -29.09% in over the last four-week period, additionally sinking by -80.24% over the last 6 months – not to mention a drop of -85.08% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OCGN stock in for the last two-week period is set at 38.60, with the RSI for the last a single of trading hit 38.15, and the three-weeks RSI is set at 40.02 for Ocugen Inc. [OCGN]. The present Moving Average for the last 50 days of trading for this stock 3.01, while it was recorded at 2.26 for the last single week of trading, and 5.75 for the last 200 days.

Insight into Ocugen Inc. Fundamentals:

Ocugen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 14.70 and a Current Ratio set at 14.70.

Ocugen Inc. [OCGN] Insider Position Details

There are presently around $150 million, or 37.40% of OCGN stock, in the hands of institutional investors. The top three institutional holders of OCGN stocks are: STATE STREET CORP with ownership of 14,017,619, which is approximately 23.858% of the company’s market cap and around 0.80% of the total institutional ownership; BLACKROCK INC., holding 12,931,131 shares of the stock with an approximate value of $30.26 million in OCGN stocks shares; and VANGUARD GROUP INC, currently with $24.82 million in OCGN stock with ownership of nearly -2.468% of the company’s market capitalization.

71 institutional holders increased their position in Ocugen Inc. [NASDAQ:OCGN] by around 11,974,547 shares. Additionally, 50 investors decreased positions by around 3,071,378 shares, while 19 investors held positions by with 48,939,162 shares. The mentioned changes placed institutional holdings at 63,985,087 shares, according to the latest SEC report filing. OCGN stock had 32 new institutional investments in for a total of 2,750,709 shares, while 20 institutional investors sold positions of 1,977,998 shares during the same period.